• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

EVOTF:US

4.9200 USD 0.5300 9.72%

As of 09:58:10 ET on 04/16/2014.

Snapshot for Evotec AG (EVOTF)

Open: 4.9200 Day's Range: 4.9200 - 4.9200 Volume: 700
Previous Close: 5.4500 52wk Range: 2.7900 - 6.2900 1-Yr Rtn: -

Stock Chart for EVOTF

No chart data available.
  • EVOTF:US 4.9200
  • 1D
  • 1M
  • 1Y
5.4500
Interactive EVOTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVOTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 114.7492
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 0.0310
Est. PEG Ratio 2.3418
Market Cap (M USD) 647.02
Shares Outstanding (M) 131.51
30 Day Average Volume 4,963
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVOTF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for EVOTF

Evotec AG offers drug research, development, and manufacturing services. The Company offers assay development and screening and compound optimization services to pharmaceutical companies. Evotec also develops drugs on its own for out-licensing.

Colin BondCFO/Member-Mgmt BoardMario PolywkaCOO/Member-Mgmt Bd
Cord E DohrmannChief Scientific Officer
More Company Profile & Key Executives for EVOTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
  • EVOTF News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil